ConductScience.org, home

Paper3914545

A review of metabolite kinetics.

Pang KS. J Pharmacokinet Biopharm, 1985. Cited by 70 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. A review of metabolite kinetics. Papers, record 3914545. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/3914545

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
A review of metabolite kinetics.
PubMed
Journal
J Pharmacokinet Biopharm
PubMed
Year
1985
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't, Review
PubMed
Citations, by iCite
70
iCite
Relative citation ratio, by iCite
3.74
iCite
Revised in PubMed
2019-10-22
PubMed

Authors1

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Pang KSK S

Source PubMed

Topics7

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Pharmaceutical PreparationsMajor topic
Animals
Biotransformation
Humans
Injections, Intravenous
Kinetics
Liver

Source PubMed

References41

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
17,288,602Dose- and time-dependent elimination of acetaminophen in rats: pharmacokinetic implications of cosubstrate depletion.J Pharmacol Exp Ther1981https://conductscience.org/library/papers/7288602PubMed
26,106,488Pharmacokinetics of benzodiazepines. Short-acting versus long-acting.Arzneimittelforschung1980https://conductscience.org/library/papers/6106488PubMed
3641,815Theoretical relationships between area under the curve and route of administration of drugs and their precursors for evaluating sites and pathways of metabolism.J Pharm Sci1978https://conductscience.org/library/papers/641815PubMed
4480,149Sequential first-pass elimination of a metabolite derived from a precursor.J Pharmacokinet Biopharm1979https://conductscience.org/library/papers/480149PubMed
56,032,052Kinetic considerations relating to the accrual and elimination of drug metabolites.Br J Pharmacol Chemother1967https://conductscience.org/library/papers/6032052PubMed
6978,394Pharmacokinetics of isoniazid and some metabolites in man.J Pharmacokinet Biopharm1976https://conductscience.org/library/papers/978394PubMed
72,858,375Metabolism of acetaminophen and phenacetin by isolated rat hepatocytes. A system in which the spatial organization inherent in the liver is disrupted.Drug Metab Dispos1985https://conductscience.org/library/papers/2858375PubMed
8731,406A theoretical examination of the effects of gut wall metabolism, hepatic elimination, and enterohepatic recycling on estimates of bioavailability and of hepatic blood flow.J Pharmacokinet Biopharm1978https://conductscience.org/library/papers/731406PubMed
914,098,474EXCRETION AND THE ACCRUAL OF DRUG METABOLITES.Nature1963https://conductscience.org/library/papers/14098474PubMed
106,034,239Treatment of data from drug urinary excretion.Nature1967https://conductscience.org/library/papers/6034239PubMed
117,310,646Metabolite to parent drug concentration ratio as a function of parent drug extraction ratio: cases of nonportal route of administration.J Pharmacokinet Biopharm1981https://conductscience.org/library/papers/7310646PubMed
12100,595Pharmacokinetics of carbamazepine-10,11- epoxide before and after autoinduction in rhesus monkeys.J Pharmacol Exp Ther1978https://conductscience.org/library/papers/100595PubMed
137,288,601Aberrant Pharmacokinetics of harmol in the perfused rat liver preparation: sulfate and glucuronide conjugations.J Pharmacol Exp Ther1981https://conductscience.org/library/papers/7288601PubMed
147,144,740Rates of sulfation and glucuronidation of 7-hydroxycoumarin in periportal and pericentral regions of the liver lobule.Mol Pharmacol1982https://conductscience.org/library/papers/7144740PubMed
156,102,028Metabolite pharmacokinetics: methods for simultaneous estimates of elimination rate constants of a drug and its metabolite. A commentary.Drug Metab Dispos1980https://conductscience.org/library/papers/6102028PubMed
165,416,180Two-compartment model for a drug and its metabolite: application to acetylsalicylic acid pharmacokinetics.J Pharm Sci1970https://conductscience.org/library/papers/5416180PubMed
174,032,242General method for evaluating the fraction of the irreversible organ clearance due to conversion of drug to a primary metabolite.J Pharm Sci1985https://conductscience.org/library/papers/4032242PubMed
187,048,351Drug metabolite kinetics.Pharmacol Ther1981https://conductscience.org/library/papers/7048351PubMed
197,252,793Symbols in pharmacokinetics.J Pharmacokinet Biopharm1980https://conductscience.org/library/papers/7252793PubMed
20702,339Kinetics of metabolite formation and elimination in the perfused rat liver preparation: differences between the elimination of preformed acetaminophen and acetaminophen formed from phenacetin.J Pharmacol Exp Ther1978https://conductscience.org/library/papers/702339PubMed

See all 41 references

Cited by17

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 70 citations.

PMIDTitleJournalYearIn PapersSource
40,264,990
Pharmacokinetics of cannabidiol, (-)-trans-Δ9-tetrahydrocannabinol, and their oxidative metabolites after intravenous and oral administration of a cannabidiol-dominant full-spectrum hemp product to beagle dogs.
Front Vet Sci2025https://conductscience.org/library/papers/40264990PubMed
32,055,581Understanding the pharmacokinetics of reversible metabolism.Transl Clin Pharmacol2019https://conductscience.org/library/papers/32055581PubMed
32,055,540Understanding the pharmacokinetics of prodrug and metabolite.Transl Clin Pharmacol2018https://conductscience.org/library/papers/32055540PubMed
22,807,110In vivo-formed versus preformed metabolite kinetics of trans-resveratrol-3-sulfate and trans-resveratrol-3-glucuronide.Drug Metab Dispos2012https://conductscience.org/library/papers/22807110PubMed
21,153,869Physiologically-based pharmacokinetic modeling for absorption, transport, metabolism and excretion.J Pharmacokinet Pharmacodyn2010https://conductscience.org/library/papers/21153869PubMed
11,587,492A physiologically based pharmacokinetic analysis of capecitabine, a triple prodrug of 5-FU, in humans: the mechanism for tumor-selective accumulation of 5-FU.Pharm Res2001https://conductscience.org/library/papers/11587492PubMed
9,625,274Pharmacokinetics of a nootropic agent, BMY-21502, and its metabolites in beagle dogs.Eur J Drug Metab Pharmacokinet1998https://conductscience.org/library/papers/9625274PubMed
9,561,490Metabolite mean transit times in the liver as predicted by various models of hepatic elimination.J Pharmacokinet Biopharm1997https://conductscience.org/library/papers/9561490PubMed
3,259,856Pharmacokinetic advantages of erythromycin estolate over ethylsuccinate as determined by high-pressure liquid chromatography.Antimicrob Agents Chemother1988https://conductscience.org/library/papers/3259856PubMed
3,199,316Primary, secondary, and tertiary metabolite kinetics.J Pharmacokinet Biopharm1988https://conductscience.org/library/papers/3199316PubMed
2,715,930An area function method for calculating the apparent elimination rate constant of a metabolite.J Pharmacokinet Biopharm1989https://conductscience.org/library/papers/2715930PubMed
2,469,080Metabolite formation pharmacokinetics: rate and extent of metabolite formation determined by deconvolution.Pharm Res1988https://conductscience.org/library/papers/2469080PubMed
2,379,537Nonlinear kinetics of propafenone metabolites in healthy man.Eur J Clin Pharmacol1990https://conductscience.org/library/papers/2379537PubMed
2,335,047Use of metabolite AUC data in bioavailability studies to discriminate between absorption and first-pass extraction.Clin Pharmacokinet1990https://conductscience.org/library/papers/2335047PubMed
2,266,497Physiological modeling of drug and metabolite: disposition of oxazepam and oxazepam glucuronides in the recirculating perfused mouse liver preparation.J Pharmacokinet Biopharm1990https://conductscience.org/library/papers/2266497PubMed
1,875,284An initial slope method for model structure: independent estimation of the elimination rate constant of a metabolite.J Pharmacokinet Biopharm1991https://conductscience.org/library/papers/1875284PubMed
1,409,378Pharmacokinetic analysis of the structural requirements for forming "stable" analogues of valpromide.Pharm Res1992https://conductscience.org/library/papers/1409378PubMed

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/3914545

GET https://conductscience.org/api/papers/v1/3914545/references?page=2